You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. SBIR Phase II: Remediation of recalcitrant and emerging environmental organic contaminants of concern using bacterial approaches

    SBC: ALLIED MICROBIOTA LLC            Topic: CT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is addressing the critical societal need to remediate toxic organic pollutants in soils and sediments. The proposed technology would enable environmental goals to be met on many contaminated sites whose remediation is currently limited by high costs. The technology would contribute to the re-developme ...

    SBIR Phase II 2019 National Science Foundation
  2. SBIR Phase II: Bluebird: Integrated IoT for Educators and Learners

    SBC: INVENT-ABLING LLC            Topic: EA

    This Small Business Innovation Research (SBIR) Phase II project develops a low-cost gateway for hands-on exploration and advances knowledge of Internet of things (IoT) fundamentals for educators and learners. The overarching goal of the project is to transform the current STEM landscape with an alternative, future-forward approach to designing connected devices, and to introduce a wide range of st ...

    SBIR Phase II 2019 National Science Foundation
  3. Green Process for Plastic Chrome

    SBC: VERGASON TECHNOLOGY INC            Topic: 18NCERP2

    This green approach to manufacturing plastic with decorative chrome will eliminate health and environmental hazards from the chrome electroplating process. The US and global market for decorative chrome on plastic is12 million m2/year and 84 million m2/year respectively, with 80% in automobile trim, 10% in appliances and 10% in sanitary fixtures. Without a viable commercial alternative, US provide ...

    SBIR Phase II 2019 Environmental Protection Agency
  4. An Enhanced Contact Plasma Reactor: A Competitive Large Treatment Capacity Remediation Technology for PFAS Contaminated Water

    SBC: DMAX PLASMA, INC.            Topic: 18NCERP2

    Manufacture and disposal of poly- and perfluoroalkyl substance (PFAS) containing-products including the historical use of aqueous film forming foam (AFFF) formulations containing PFAS has resulted in PFAS contamination of numerous water supplies. Recent reports indicate the Air Force alone is expecting to spend > $2.25 billion for cleanup for PFAS-contaminated sites. Our technology, based on the g ...

    SBIR Phase II 2019 Environmental Protection Agency
  5. Co-culture cassette for anaerobes and primary human intestinal epithelium

    SBC: Altis Biosystems, Inc.            Topic: 300

    Project SummaryThe human colon is a remarkable organ, playing critical roles in drug uptake and metabolism as well as harboring the 100 trillion microbial cells of the microbiome, which itself has multiple impacts on human health. For these reasons, there is a widespread need in academia and the biotechnology marketplace for in vitro studies of human colon physiology and the interaction between co ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  6. BD2K product for enhancing phenotypic screens

    SBC: GENECENTRIX INC.            Topic: NIDA

    The public health problem addressed by the proposed project is the critical, long-term absence of progress in anti-addiction medication discovery and development. GeneCentrix’ “historeceptomics” technology has the potential to alter this trend by providing advanced insights during the process of anti-addiction medication discovery and development. Digital/computational advanced insights are ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  7. Novel Home-Based and Low-Cost ECG Device for periodic evaluation of the presence of atrial fibrillation

    SBC: Global Instrumentation, LLC            Topic: 600

    Abstract Atrial fibrillation (AF) prevalence is estimated to 1% of the general population in the United States. A shocking 30% to 60% (according to studies) of patients with AF are unaware of their diagnosis (silent AF). Most AF patients will suffer from congestive heart failure or/and develop thromboembolic events leading to a dramatic reduction of patients’ quality of life, and a significant c ...

    STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  8. SBIR Phase II: An adaptive machine learning-based platform to improve surgical quality and patient outcomes

    SBC: Kelahealth Inc.            Topic: SH

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will be to help usher in personalized and tailored surgical care within a shifting healthcare context toward value-based care. Hospitals and surgeons are seeking solutions that will enable them to target, as opposed to generalizing, improvements in surgical quality for enhanced patient outcom ...

    SBIR Phase II 2019 National Science Foundation
  9. GMP Production of a Tau Oligomer Inhibitor to Enable Clinical Development for ADRD

    SBC: OLIGOMERIX INC            Topic: NIA

    TITLE: GMP Synthesis of a Tau Oligomer Inhibitor to Enable Clinical Development for ADRD PROJECT SUMMARY - SBIR Funding Opportunity: NIA PAS-18-187, andquot;Advancing Research on Alzheimerandapos;s Disease (AD) andamp; AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)andquot; The long-term goal of this program is to develop a disease-modifying, small molecule drug for Alzheimer’s dis ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  10. A diabetes pill to replace insulin injections

    SBC: BIOORG3.14 LLC            Topic: 200

    The overall goal of this program is to develop an oral replacement for injecting insulin. The central premise of this work is that a small molecule called BG-148, or similar molecules, can be taken orally in place of injecting insulin to aid in glycemic control. BG-148 could completely replace insulin injections or could reduce insulin injections by half. To begin clinical testing to evaluate this ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government